Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Abnormally high expression of HOXA2 as an independent factor for poor prognosis in glioma patients.

Cell cycle (Georgetown, Tex.) - 1 Jul 2020

Liu Zhendong, Shen Fei, Wang Hongbo, Li Ang, Wang Jialin, Du Lin, Liu Binfeng, Zhang Bo, Lian Xiaoyu, Pang Bo, Liu Liyun, Gao Yanzheng

Abstract excerpt

In recent years, studies have revealed HOXA2 as a new oncogene, but its function is unknown in gliomas. We aimed to reveal the relationship between HOXA2 and glioma based on the Chinese Glioma Genome Atlas(CGGA) and the cancer genome atlas (TCGA). HOXA2 expression data and clinically relevant information of glioma patients were obtained from the CGGA and TCGA containing 1447 glioma tissues and five non-tumor...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Brain Neoplasms
Share to Gene Expression Regulation, Neoplastic

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Glioma

Share to Homeodomain Proteins

Share to Kaplan-Meier Estimate

Share to Multivariate Analysis

Share to Prognosis

Share to Reproducibility of Results

Source

Open in PubMed Open full text

Identifiers

PMID: 32436804
DOI: 10.1080/15384101.2020.1762038
PMCID: PMC7469623

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 5 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Abnormally high expression of HOXA2 as an independent factor for poor prognosis in glioma patients.PMID 32436804Read ↗

High expression of HOXA4 in patients with glioma indicates unfavorable clinical outcomes.Semantic proximity Read ↗

LncRNA HOXA11-AS promotes glioma malignant phenotypes and reduces its sensitivity to ROS via Tpl2-MEK1/2-ERK1/2 pathway.Semantic proximity Read ↗

ANXA2 is correlated with the molecular features and clinical prognosis of glioma, and acts as a potential marker of immunosuppressionSemantic proximity Read ↗

LncRNA HOXA11-AS promotes gliomas malignant phenotypes and reduces its sensitivity to ROS via Tpl2-MEK1/2-ERK1/2 pathwaySemantic proximity Read ↗

ANXA2 is Correlated With the Molecular Features and Clinical Prognosis of Glioma, and Acts as a Potential Marker of ImmunosuppressionSemantic proximity Read ↗

Identification of a gene signature associated with radiotherapy and prognosis in gliomasSemantic proximity Read ↗

PAXIP1-AS2 is a Promising Target for Glioma Progression and TreatmentSemantic proximity Read ↗

FXYD2 mRNA expression represents a new independent factor that affects survival of glioma patients and predicts chemosensitivity of patients to temozolomide.Semantic proximity Read ↗

HOXB2 Is a Prognostic Biomarker and Correlated with Immune Infiltration in Colorectal Cancer and GliomaSemantic proximity Read ↗

Predictive value of focal adhesion-related genes for prognosis and response to immunotherapy in glioma patientsSemantic proximity Read ↗

TMEM2 Combined with IDH and 1p19q in Refining Molecular Subtypes for Predicting Survival of Patients with Glioma.Semantic proximity Read ↗

Long non-coding RNA HOXA-AS2 may serve as a new therapeutic target and promising prognostic market for most of cancersSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.